| scholarly article | Q13442814 |
| P2093 | author name string | B Angelin | |
| M Rudling | |||
| C Gälman | |||
| P2860 | cites work | Role of bile acids and bile acid receptors in metabolic regulation | Q37363616 |
| Gender-related differences in bile acid and sterol metabolism in outbred CD-1 mice fed low- and high-cholesterol diets | Q42461790 | ||
| Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum | Q42536204 | ||
| Bowel habits and bile acid malabsorption in the months after cholecystectomy | Q43354701 | ||
| Aging per se is an independent risk factor for cholesterol gallstone formation in gallstone susceptible mice | Q44195506 | ||
| Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood | Q44300068 | ||
| Spontaneous gallstone formation in deer mice: interaction of cholesterol, bile acids, and dietary fiber | Q44396755 | ||
| Bile acid synthesis is increased in Chilean Hispanics with gallstones and in gallstone high-risk Mapuche Indians | Q44779678 | ||
| Sex differences in the size of bile acid pools | Q47317121 | ||
| Bile Acid Pools, Kinetics and Biliary Lipid Composition before and after Cholecystectomy | Q50160659 | ||
| Circulating markers for biosynthesis of cholesterol and bile acids are not depressed in asymptomatic gallstone subjects. | Q50942168 | ||
| Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. | Q51485180 | ||
| Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity | Q56803429 | ||
| FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis | Q24617480 | ||
| Bile acids: regulation of synthesis | Q24658139 | ||
| Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia | Q28210995 | ||
| Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation | Q28290455 | ||
| The plasma level of 7 alpha-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7 alpha-hydroxylase in man | Q28328404 | ||
| FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways | Q28741802 | ||
| Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis | Q29619610 | ||
| Bile acids and lipoprotein metabolism: a renaissance for bile acids in the post-statin era? | Q33702424 | ||
| Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c | Q33785270 | ||
| Influence of age on the metabolism of plasma low density lipoproteins in healthy males | Q34237195 | ||
| Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. | Q34300009 | ||
| Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia | Q34335375 | ||
| Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis | Q34467201 | ||
| Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;. | Q34470272 | ||
| Enterohepatic circulation of bile acids after cholecystectomy | Q34474514 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 580-588 | |
| P577 | publication date | 2011-11-02 | |
| P1433 | published in | Journal of Internal Medicine | Q6295387 |
| P1476 | title | Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. | |
| P478 | volume | 270 |
| Q36942098 | A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass |
| Q51110518 | Acute caloric restriction counteracts hepatic bile acid and cholesterol deficiency in morbid obesity. |
| Q35993511 | Age-Related Changes of Plasma Bile Acid Concentrations in Healthy Adults--Results from the Cross-Sectional KarMeN Study |
| Q37655440 | Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population |
| Q91657985 | Bile Acid Diarrhea and NAFLD: Shared Pathways for Distinct Phenotypes |
| Q50024681 | Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet |
| Q38198859 | Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy |
| Q47645986 | Bile acid metabolism in liver pathobiology |
| Q28244875 | Bile acid signaling in metabolic disease and drug therapy |
| Q48042610 | Bile acids in glucose metabolism in health and disease |
| Q50535134 | Characterizing Factors Associated With Differences in FGF19 Blood Levels and Synthesis in Patients With Primary Bile Acid Diarrhea. |
| Q48319424 | Chenodeoxycholic acid stimulated fibroblast growth factor 19 response - a potential biochemical test for bile acid diarrhoea. |
| Q50660119 | Cholestyramine treatment of healthy humans rapidly induces transient hypertriglyceridemia when treatment is initiated. |
| Q38212026 | Combined effect of plant sterols and dietary fiber for the treatment of hypercholesterolemia |
| Q41873388 | Control of lipid metabolism by adipocyte FGFR1-mediated adipohepatic communication during hepatic stress |
| Q55065719 | Detection technologies and metabolic profiling of bile acids: a comprehensive review. |
| Q36414100 | Determinants of post-prandial plasma bile acid kinetics in human volunteers |
| Q28593904 | Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels |
| Q39563092 | Diet1 is a regulator of fibroblast growth factor 15/19-dependent bile acid synthesis |
| Q47237068 | Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants |
| Q51318198 | Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea. |
| Q42263341 | Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea. |
| Q34366988 | Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention |
| Q51287817 | Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin. |
| Q99604573 | Identification of Glycochenodeoxycholate 3-O-Glucuronide and Glycodeoxycholate 3-O-Glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers |
| Q39208620 | Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS. |
| Q35014317 | Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol |
| Q37047115 | Inhibition of ileal apical but not basolateral bile acid transport reduces atherosclerosis in apoE⁻/⁻ mice |
| Q28729212 | Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice |
| Q92116089 | Isotopic dilution method for bile acid profiling reveals new sulfate glycine-conjugated dihydroxy bile acids and glucuronide bile acids in serum |
| Q50168976 | Long-term administration of a Niemann-Pick C1-like 1 inhibitor, ezetimibe, does not worsen bile lithogenicity in dyslipidemic patients with hepatobiliary diseases |
| Q42622908 | Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism |
| Q61799895 | Non-Cholesterol Sterol Concentrations as Biomarkers for Cholesterol Absorption and Synthesis in Different Metabolic Disorders: A Systematic Review |
| Q34791055 | Not all (bile acids) who wander are lost: the first report of a patient with an isolated NTCP defect |
| Q43270593 | Novel associations of bile acid diarrhoea with fatty liver disease and gallstones: a cohort retrospective analysis |
| Q42938750 | Novel regulator of enterohepatic bile acid signaling protects against hypercholesterolemia |
| Q55345479 | Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature. |
| Q89837444 | Of mice and men: murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism |
| Q36843966 | Pleiotropic roles of bile acids in metabolism |
| Q37584099 | Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge |
| Q38112366 | Recycling rate of bile acids in the enterohepatic recirculation as a major determinant of whole body 75SeHCAT retention. |
| Q35836340 | Regulation of bile acid homeostasis by the intestinal Diet1-FGF15/19 axis |
| Q39171887 | Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases |
| Q35577851 | Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes. |
| Q34444158 | The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid. |
| Q50157113 | Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III. |
| Q92761085 | XX sex chromosome complement promotes atherosclerosis in mice |
Search more.